JD Health (06618) Launches Evidence-Based Medical AI Product "Zhiyi" to Support Doctors in Clinical and Research Settings

Stock News01-17

On January 17, the 2026 JD Health Annual Doctor Summit was grandly held in Beijing. At the event, JD Health significantly launched "Zhiyi," an evidence-based medical AI product specifically designed for doctors. According to the introduction, this product focuses on two core scenarios: clinical decision-making and academic research, deeply integrating tens of millions of authoritative global medical data points. It can rapidly screen and highly synthesize vast amounts of authoritative literature and guidelines, directly outputting actionable conclusions to enhance the quality and efficiency of doctors' clinical diagnosis and treatment, while providing robust support for scientific research exploration. It is reported that "Zhiyi" will be fully integrated into the JD Doctor APP and made available for all doctors to experience; regardless of whether they are affiliated with JD Internet Hospital, they can utilize this evidence-based medical AI product.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment